MedTrace Logo

Acute Treatment of Migraine With e-TNS

NCT02590939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2018-06-06

Study results available
· View outcomes & findings →

Summary

The main objective of this study is to assess the efficacy of the Cefaly® device as an acute treatment of migraine attack in adult patients. The patients will be applied either an active or placebo external neurostimulation for 1 hour during a migraine attack, and will report the pain on a visual analog scale before and after the treatment.

Conditions

Interventions

DEVICE

CEFALY Active

Active external trigeminal nerve stimulation

DEVICE

CEFALY Placebo

Placebo external trigeminal nerve stimulation

Sponsors & Collaborators

  • Cefaly Technology

    lead INDUSTRY

Principal Investigators

  • Denise Chou, M.D. · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02590939 on ClinicalTrials.gov